🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this research is to measure certain indicators of resilien...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-09-28
Trial ID
NCT04188678
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and melpha...
Status
Terminated
Location
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Start Date
2005-07
Trial ID
NCT00121186
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
The main purpose of this study is to examine the outcome of a combined bone...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2012-11
Trial ID
NCT01758042
Treatments Being Tested
Women undergoing myeloablative allogeneic hematopoietic cell transplant (MA...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-07
Trial ID
NCT01343368
Treatments Being Tested
The purpose of this pivotal study is to determine if intravenous Rezafungin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-11
Trial ID
NCT04368559
Primary Objective: 1\. To determine efficacy of escalating doses of pentos...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2000-09
Trial ID
NCT00506922
Treatments Being Tested
This is a Phase II multi-center trial single arm trial of autologous transp...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2021-10-25
Trial ID
NCT04975698
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
Primary Objective: 1\. To use the results from this pilot study to estimat...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09
Trial ID
NCT00507260
Treatments Being Tested